172 related articles for article (PubMed ID: 36736702)
1. Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle.
Maturana CJ; Chan A; Verpeut JL; Engel EA
J Virol Methods; 2023 Apr; 314():114688. PubMed ID: 36736702
[TBL] [Abstract][Full Text] [Related]
2. Persistent transgene expression in peripheral tissues one year post intravenous and intramuscular administration of AAV vectors containing the alphaherpesvirus latency-associated promoter 2.
Maturana CJ; Engel EA
Front Virol; 2024; 4():. PubMed ID: 38665693
[TBL] [Abstract][Full Text] [Related]
3. Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver.
Maturana CJ
Gene Ther; 2024 May; 31(5-6):335-344. PubMed ID: 38012300
[TBL] [Abstract][Full Text] [Related]
4. Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in the CNS.
Maturana CJ; Verpeut JL; Pisano TJ; Dhanerawala ZM; Esteves A; Enquist LW; Engel EA
Mol Ther Methods Clin Dev; 2020 Jun; 17():843-857. PubMed ID: 32368565
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.
Katwal AB; Konkalmatt PR; Piras BA; Hazarika S; Li SS; John Lye R; Sanders JM; Ferrante EA; Yan Z; Annex BH; French BA
Gene Ther; 2013 Sep; 20(9):930-8. PubMed ID: 23535898
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
[TBL] [Abstract][Full Text] [Related]
7. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
[TBL] [Abstract][Full Text] [Related]
8. Insulin Therapy Improves Adeno-Associated Virus Transduction of Liver and Skeletal Muscle in Mice and Cultured Cells.
Carrig S; Bijjiga E; Wopat MJ; Martino AT
Hum Gene Ther; 2016 Nov; 27(11):892-905. PubMed ID: 27358030
[TBL] [Abstract][Full Text] [Related]
9. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
[TBL] [Abstract][Full Text] [Related]
11. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
12. Targeting transgene to the heart and liver with AAV9 by different promoters.
Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
[TBL] [Abstract][Full Text] [Related]
13. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.
Chai Z; Zhang X; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2018 Sep; 286():415-424. PubMed ID: 30107215
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle.
Léger A; Le Guiner C; Nickerson ML; McGee Im K; Ferry N; Moullier P; Snyder RO; Penaud-Budloo M
PLoS One; 2011; 6(6):e20881. PubMed ID: 21687632
[TBL] [Abstract][Full Text] [Related]
15. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
[TBL] [Abstract][Full Text] [Related]
16. K137R mutation on adeno-associated viral capsids had minimal effect on enhancing gene delivery in vivo.
Qiao C; Li C; Zhao C; Li J; Bian T; Grieger J; Li J; Samulski RJ; Xiao X
Hum Gene Ther Methods; 2014 Feb; 25(1):33-9. PubMed ID: 24116972
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.
Chai Z; Zhang X; Dobbins AL; Rigsbee KM; Wang B; Samulski RJ; Li C
Hum Gene Ther; 2019 Jul; 30(7):829-840. PubMed ID: 30700148
[TBL] [Abstract][Full Text] [Related]
18. Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector.
Tarantal AF; Lee CCI; Martinez ML; Asokan A; Samulski RJ
Hum Gene Ther; 2017 May; 28(5):385-391. PubMed ID: 28125921
[TBL] [Abstract][Full Text] [Related]
19. Single tyrosine mutation in AAV8 and AAV9 capsids is insufficient to enhance gene delivery to skeletal muscle and heart.
Qiao C; Yuan Z; Li J; Tang R; Li J; Xiao X
Hum Gene Ther Methods; 2012 Feb; 23(1):29-37. PubMed ID: 22428978
[TBL] [Abstract][Full Text] [Related]
20. JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-mediated Transgene Expression in the Lung and Liver of Mice.
Yu DL; Chow N; Wootton SK
Viruses; 2020 Nov; 12(11):. PubMed ID: 33172105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
